Log in
Enquire now
‌

US Patent 6949645 Process for the production of opiates

Patent 6949645 was granted and assigned to Acura Pharmaceuticals on September, 2005 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
0
Current Assignee
Acura Pharmaceuticals
Acura Pharmaceuticals
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
69496450
Patent Inventor Names
Charles A. Francis0
Date of Patent
September 27, 2005
0
Patent Application Number
108496960
Date Filed
May 20, 2004
0
Patent Citations Received
‌
US Patent 12018304 Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same
0
‌
US Patent 11859225 Methods of producing epimerases and benzylisoquinoline alkaloids
0
Patent Primary Examiner
‌
Charanjit S. Aulakh
0
Patent abstract

A morphine component, e.g., a concentrate of poppy straw, is converted into codeine in high yield and high purity and in a highly controlled manner. The conversion process involves the following steps: (a) providing a solution or suspension of a morphine component in an inert solvent or a mixture of solvents; (b) methylating the resultant solution or suspension with a methylating agent in the presence of an alkaline ingredient; and (c) recovering the resultant codeine as the free base or as a salt.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 6949645 Process for the production of opiates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.